[go: up one dir, main page]

BRPI0509053A - composição farmacêutica anidra e uso de um agente siliconado e de uma composição - Google Patents

composição farmacêutica anidra e uso de um agente siliconado e de uma composição

Info

Publication number
BRPI0509053A
BRPI0509053A BRPI0509053-9A BRPI0509053A BRPI0509053A BR PI0509053 A BRPI0509053 A BR PI0509053A BR PI0509053 A BRPI0509053 A BR PI0509053A BR PI0509053 A BRPI0509053 A BR PI0509053A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
anhydrous pharmaceutical
silicon agent
agent
composition
Prior art date
Application number
BRPI0509053-9A
Other languages
English (en)
Inventor
Claire Mallard
Eve Ferrara
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI0509053A publication Critical patent/BRPI0509053A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSIçãO FARMACêUTICA ANIDRA E USO DE UM AGENTE SILICONADO E DE UMA COMPOSIçãO A invenção refere-se a uma composição farmacêutica anidra, associando pelo menos um princípio ativo e um agente siliconado compreendendo pelo menos um elastómero organopolissiloxano, sendo que o referido princípio ativo encontra-se em forma solubilizada na referida composição.
BRPI0509053-9A 2004-03-22 2005-03-18 composição farmacêutica anidra e uso de um agente siliconado e de uma composição BRPI0509053A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0402911A FR2867682B1 (fr) 2004-03-22 2004-03-22 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
PCT/FR2005/050171 WO2005092347A2 (fr) 2004-03-22 2005-03-18 Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise

Publications (1)

Publication Number Publication Date
BRPI0509053A true BRPI0509053A (pt) 2007-08-21

Family

ID=34896683

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509053-9A BRPI0509053A (pt) 2004-03-22 2005-03-18 composição farmacêutica anidra e uso de um agente siliconado e de uma composição

Country Status (12)

Country Link
US (1) US20070135379A1 (pt)
EP (1) EP1753436A2 (pt)
JP (1) JP2007530515A (pt)
KR (1) KR20070032629A (pt)
CN (1) CN1938033A (pt)
AU (1) AU2005225186A1 (pt)
BR (1) BRPI0509053A (pt)
CA (1) CA2558884A1 (pt)
FR (1) FR2867682B1 (pt)
MX (1) MXPA06010767A (pt)
RU (1) RU2006137291A (pt)
WO (1) WO2005092347A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2909284B1 (fr) 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
US20080145443A1 (en) 2006-12-15 2008-06-19 Kimberly-Clark Worldwide, Inc. Diaper rash composition and method
US20080188445A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
WO2008097851A1 (en) * 2007-02-02 2008-08-14 Warner Chilcott Company, Inc. Tetracycline compositions for topical administration
US8425923B2 (en) * 2007-02-09 2013-04-23 Dow Corning Corporation and McNeil-PPC, Inc. Lotion composition for personal use
KR101494299B1 (ko) * 2007-02-09 2015-02-17 레킷트 뱅키저 (브랜즈) 리미티드 개인 용도를 위한 로션 조성물
GB0919650D0 (en) * 2009-11-10 2009-12-23 Futura Medical Developments Ltd Pharmaceutical composition
CA2834301A1 (en) * 2011-05-02 2012-11-08 Lipidor Ab Treatment of psoriasis
WO2012158448A2 (en) * 2011-05-13 2012-11-22 Quadsil, Inc. Compositions comprising siloxane polymer
ES2401806B1 (es) * 2011-10-11 2014-06-10 Servicio Andaluz De Salud Uso de una composición que comprende un poli-organosiloxano.
EP2796149A4 (en) 2011-12-21 2015-07-15 Maruho Kk SKIN COMPOSITION CONTAINING SILICONE BASE
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
EP2641585A1 (en) * 2012-03-19 2013-09-25 Coty Germany GmbH Cosmetic skin composition with soothing effect and its use
JP6093007B2 (ja) * 2012-04-27 2017-03-08 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
GB201503590D0 (en) * 2015-03-03 2015-04-15 Davis Adrian Topical formulation
BR112019017045A2 (pt) * 2017-02-15 2020-04-14 Botanix Pharmaceuticals Ltd composições para tratar acne
EP3979985A4 (en) * 2019-06-07 2023-05-03 Paxmedica, Inc. COMPOSITIONS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4574082A (en) * 1983-07-29 1986-03-04 Revlon, Inc. One-phase silicone-based cosmetic products containing wax
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
JPS62143970A (ja) * 1985-12-17 1987-06-27 Shin Etsu Chem Co Ltd ゲル状組成物
JPS62243621A (ja) * 1986-04-17 1987-10-24 Toray Silicone Co Ltd シリコ−ンゴム粒状物の製造方法
FI872553A7 (fi) * 1986-06-09 1987-12-10 American Cyanamid Co Paikallisesti käytettävien lääkeaineiden väliaine.
JPH0753646B2 (ja) * 1989-01-31 1995-06-07 東レ・ダウコーニング・シリコーン株式会社 化粧料
GB9109733D0 (en) * 1991-05-07 1991-06-26 Unilever Plc Cosmetic composition
FR2719220A1 (fr) * 1994-04-29 1995-11-03 Lafon Labor Nouvelle forme galénique pour l'administration transdermique.
FR2740038B1 (fr) * 1995-10-20 1998-01-02 Lafon Labor Composition pour l'administration transdermique
US5654362A (en) * 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5929164A (en) * 1997-11-05 1999-07-27 Dow Corning Corporation Quenching post cure
EP0966972B1 (en) * 1998-06-18 2003-09-24 Dow Corning France S.A. Topical composition containing silicon gum
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
JP2001002555A (ja) * 1999-06-24 2001-01-09 Shin Etsu Chem Co Ltd 皮膚化粧料
US6103250A (en) * 1999-07-06 2000-08-15 Revlon Consumer Products Corporation Anhydrous cosmetic compositions containing emulsifying siloxane elastomer
JP4215918B2 (ja) * 1999-12-28 2009-01-28 日本メナード化粧品株式会社 化粧料
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
PL378172A1 (pl) * 2003-02-05 2006-03-06 Galderma Research & Development, S.N.C. Kompozycja typu odwrotnej emulsji, zawierająca co najmniej jeden aktywny środek wrażliwy na obecność wody, oraz jej zastosowanie w kosmetyce i dermatologii
FR2850575B1 (fr) * 2003-02-05 2007-04-13 Galderma Res & Dev Composition de type emulsion inverse contenant au moins un actif sensible a la presence d'eau, et ses utilisations en dermatologie
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
CA2543577A1 (en) * 2003-11-21 2005-06-16 Galderma Research & Development, S.N.C. Sprayable composition for the administration of vitamin d derivatives
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
KR20070027587A (ko) * 2004-06-17 2007-03-09 갈데르마 소시에떼아노님 실리콘제, 코르티코스테로이드 및 비타민 ｄ 또는 이의유도체를 함유하는 건선 치료용 조성물
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile

Also Published As

Publication number Publication date
RU2006137291A (ru) 2008-04-27
FR2867682B1 (fr) 2009-06-05
WO2005092347A2 (fr) 2005-10-06
EP1753436A2 (fr) 2007-02-21
KR20070032629A (ko) 2007-03-22
AU2005225186A1 (en) 2005-10-06
CN1938033A (zh) 2007-03-28
CA2558884A1 (fr) 2005-10-06
JP2007530515A (ja) 2007-11-01
US20070135379A1 (en) 2007-06-14
MXPA06010767A (es) 2007-07-04
WO2005092347A3 (fr) 2006-05-18
FR2867682A1 (fr) 2005-09-23

Similar Documents

Publication Publication Date Title
BRPI0509053A (pt) composição farmacêutica anidra e uso de um agente siliconado e de uma composição
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
BR0109931A (pt) Composições farmacêuticas
BRPI0717219B8 (pt) composição imunogênica, e, uso de uma composição imunogênica
BRPI0416205A (pt) uso de antibióticos como adjuvantes de vacina
BRPI0514103A (pt) dispostivo de distribuição
CL2007001724A1 (es) Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1
BRPI0409945A (pt) forma de dosagem resistente à alteração
BRPI1009842B8 (pt) uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas
ECSP088239A (es) Composición de liberación de fármaco sostenida
MXPA03001789A (es) Composiciones para el cuidado de telas que comprenden silicones cationicos y metodos que emplean las mismas.
CL2004001621A1 (es) Uso de una terapia combinada de metotrexato y otros agentes activos para el tratamiento de artritis reumatoide.
BR0311867A (pt) Forma de ministração adesiva a mucosa em forma de pelìcula e uso de um extrato ou de um óleo de cannabis para a produção de uma forma de ministração adesiva a mucosa em forma de pelìcula
DK1680128T3 (da) Myo-inositolhexaphosphat til topisk anvendelse
BR0108238A (pt) Composições cosméticas contendo pelo menos um hetero polìmero e pelo menos uma resina de silicone de formação de pelìcula e métodos de empregá-las
UY28662A1 (es) Agente endoparasiticida para administracion topica
AR060739A1 (es) Composiciones orales que comprenden polimeros de siloxano
AR041722A1 (es) Formulaciones de liberacion prolongada inyectables
BR0107667A (pt) Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo
CL2007003587A1 (es) Compuestos derivados de pirimidinas sustituidas; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para tratar o prevenir la infeccion de la hepatitis c.
GT200200200A (es) Productos para la axila, con componente de bloqueo de agua
CL2007003693A1 (es) Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
BRPI0510938A (pt) vitamina k1 como energizador em formulações cosméticas
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.